|Expense Ratio (net)||N/A|
|Last Cap Gain||N/A|
|Morningstar Risk Rating||N/A|
|Beta (3Y Monthly)||N/A|
|5y Average Return||N/A|
|Average for Category||N/A|
SINTX Technologies (SINT) today reported the independent publication of 30-year clinical outcomes of lumbar fusion surgeries, performed with silicon nitride implants. The paper titled “Anterior Lumbar Interbody Fusion Using Reaction Bonded Silicon Nitride Implants” appeared in the December 2018 edition of the World Neurosurgery journal, and the findings were also featured at the 2018 Annual Scientific Meeting of the Neurosurgical Society of Australasia. Dr. Ralph Mobbs from the University of New South Wales, Sydney, authored the study.
Amedica Corporation (AMDA), a company that develops and commercializes silicon nitride for biomedical applications, announced that it has changed its corporate name to SINTX Technologies, Inc. in order to better reflect its focus on silicon nitride science and technologies and robust pipeline of silicon nitride based products in various biomedical applications. The company expects to change its trading symbol on the NASDAQ Capital Market to “SINT” in approximately 10 days.
NEW YORK, NY / ACCESSWIRE / September 26, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...
WallStEquities.com revisits the Medical Appliances and Equipment space, which is engaged in the manufacture of medical instruments such as dental and surgical appliances. Under evaluation this morning are these four stocks: EDAP TMS S.A. (NASDAQ: EDAP), PAVmed Inc. (NASDAQ: PAVM), Amedica Corp. (NASDAQ: AMDA), and Avinger Inc. (NASDAQ: AVGR).